.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2013 for a tre...
.On the heels of a phase 3 gain that stopped working to excite investors, Ironwood Pharmaceuticals i...
.Don't cease Monte Rosa Therapies now. The Boston-based biotech is enjoying after authorizing a deal...
.Welcome to today's Chutes & Ladders, our summary of notable leadership hirings, firings and also...
.Commemorating his company's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the open...
.AbbVie has actually gone back to the source of its antipsychotic giant Vraylar trying to find anoth...
.GenSight Biologics is actually weeks off of lacking cash. Once more. The biotech only has enough ca...
.Monopar Rehabs is recouping a drug from the scrap heap of AstraZeneca's unusual illness pipeline. I...
.With brand-new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of analyst...
.After creating a genetics treatment relationship with Dyno Rehabs in 2020, Roche is actually back f...
.Lundbeck is actually slashing the book worth of its own $250 thousand Abide Rehabs buyout in reacti...
.The assimilation of real-world records (RWD) in to protocol feasibility as well as site option has ...
.At this year's Fierce Biotech Top in Boston, we overtook innovators in the biotech market who have ...
.Merck & Co. is actually setting down $30 million upfront to get Yale spinout Modifi Biosciences,...
.Alpha-9 Oncology has elevated a $175 thousand series C round to stake its own clinical-stage radiop...
.Eye medicine manufacturer Ocuphire Pharma is actually obtaining gene therapy programmer Piece Genes...
.Roche's persistent cough program has faltered to a stop. The drugmaker, which axed the system after...
.Gilead Sciences and also Merck & Co. have actually directed their once-weekly HIV mix therapy pa...
.Lykos Therapies may have lost three-quarters of its staff in the wake of the FDA's being rejected o...
.Septerna may be actually as yet to make known "any kind of significant scientific data," but the bi...